Form 4 for ZNTL Zentalis Pharmaceuticals, Inc.
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-20 · accession 0001725160-23-000203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-21 | 2023-12-20 | ZNTL | Bunker Kevin D. | CSO | G - Gift | $0.00 | -24.2K | 834.9K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | G | D | 24,158 | $0.00 | 834,931 | D | — | — | (F1) The Reporting Person transferred 24,158 shares to the Raising Hope Foundation, a charitable foundation of which the Reporting Person is a director. The Reporting Person has voting and investment power over all securities owned by the Raising Hope Foundation. |